Pharmacology Mentor

Principles and Composition of Physiological Salt Solutions

by

1. Introduction Physiological salt solutions represent a cornerstone of experimental pharmacology and physiology, providing an artificial extracellular environment that sustains the viability and functional integrity of isolated tissues and organs. These solutions are carefully formulated aqueous mixtures of inorganic salts, glucose, and sometimes other organic components, designed to mimic the ionic composition, pH, osmotic pressure, … Read more

Calculation of Dose and Concentration of Drug Solutions

by

Introduction/Overview The accurate calculation of drug doses and the preparation of solutions with precise concentrations represent fundamental competencies in clinical pharmacology. Errors in these calculations can lead to therapeutic failure or, more critically, patient harm through toxicity. Mastery of these principles is therefore not merely an academic exercise but a core component of patient safety. … Read more

Alcohol and the Liver: The Biochemical Pathways of Hepatotoxicity

by

1. Introduction The hepatotoxic effects of ethanol represent a principal cause of chronic liver disease worldwide, encompassing a spectrum of pathology from simple steatosis to steatohepatitis, fibrosis, and cirrhosis. The biochemical pathways underlying this toxicity are complex and multifactorial, involving direct metabolic injury, generation of toxic intermediates, and profound perturbations in cellular redox states, lipid … Read more

The Top 5 Drug-Drug Interactions Every Clinician Should Know

by

1. Introduction The concurrent administration of multiple pharmacotherapeutic agents is a cornerstone of modern medical practice, particularly in the management of complex, multi-morbid conditions. This polypharmacy, while often necessary, inherently elevates the risk of drug-drug interactions (DDIs). A drug-drug interaction is defined as a pharmacological or clinical response to the administration of a drug combination … Read more

Digital Therapeutics (DTx): When the “Drug” is an App

by

1. Introduction/Overview The therapeutic landscape is undergoing a significant transformation with the emergence of Digital Therapeutics (DTx). These are evidence-based, software-driven interventions intended to prevent, manage, or treat medical disorders. Unlike general wellness applications, DTx products are subject to rigorous clinical evaluation and regulatory oversight, analogous to pharmacologic agents. They are prescribed by qualified healthcare … Read more

AI in Pharmacology: How Machine Learning is Cutting Drug Discovery Time in Half

by

1. Introduction The integration of artificial intelligence (AI) and machine learning (ML) into pharmacology represents a paradigm shift in the approach to drug discovery and development. Historically characterized by high costs, protracted timelines, and significant attrition rates, the traditional drug discovery pipeline is being fundamentally reshaped by computational methodologies. This chapter provides a comprehensive examination … Read more

Personalized Medicine: How Pharmacogenomics is Ending the “One Size Fits All” Era

by

1. Introduction The paradigm of drug therapy is undergoing a fundamental transformation, shifting from population-based dosing strategies towards individualized treatment regimens. This shift is largely driven by pharmacogenomics, the study of how an individual’s genetic makeup influences their response to drugs. The traditional “one size fits all” approach to pharmacotherapy, while pragmatic for broad populations, … Read more

Transdermal Tech: Beyond the Patch—The Future of Needle-Free Medication

by

Introduction/Overview The administration of therapeutic agents has historically been constrained by the physiological barriers of the human body. The transdermal route, offering a portal of entry through the skin, presents a compelling alternative to oral and parenteral routes, circumventing first-pass metabolism and enabling controlled, non-invasive delivery. While traditional transdermal patches have established a niche for … Read more

Phytochemicals and the Brain: Can Plant-Based Agents Slow Neurodegeneration?

by

Introduction/Overview The progressive and irreversible loss of neuronal structure and function characterizes neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). With aging global populations, the socioeconomic burden of these conditions is substantial. Conventional pharmacotherapy, including acetylcholinesterase inhibitors and N-methyl-D-aspartate (NMDA) receptor antagonists for AD or dopamine replacement for PD, primarily offers symptomatic … Read more

Mechanopharmacology: The Hidden Role of Physical Forces in Drug Delivery

by

1. Introduction/Overview The traditional paradigm of pharmacology centers on the biochemical interaction between a drug molecule and its biological target. However, a more comprehensive understanding of drug action must account for the physical context in which these interactions occur. Mechanopharmacology is an emerging interdisciplinary field that investigates how physical forces and the mechanical properties of … Read more